** Shares of Indegene INEG.NS rise 1.8% to 560 rupees
** ICICI Securities initiates coverage on life sciences firm with "add" rating; sets PT at 630 rupees, implying 14.5% upside from last close
** Sees strong medium-term growth potential, distinct position in AI-enabled solutions
** Highlights global top-20 pharma clients contribute 64% of co's revenue
** Expects EPS to grow at 14.7% CAGR over FY25–FY28, reaching 25.8 rupees by FY28
** INEG rated "hold" on average by 5 analysts; median PT is 650 rupees – data compiled by LSEG
** Stock down 7.2% YTD
(Reporting by Rudra Pratap Singh in Bengaluru)
((rudrapratap.singh@thomsonreuters.com))